Bristol-Myers Worldwide Consumer Health Sales Jump 13%

Foreign sales gains in the Bufferin analgesic line - most notably in Japan - helped Bristol-Myers Squibb's worldwide consumer drug sales see a 13% increase to $274 mil. in the second quarter, the company reported July 20. Excluding foreign exchange, the segment's revenues jumped 17%.